Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2

Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidence...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2013-05, Vol.288 (21), p.15342-15351
Hauptverfasser: Sanz-Garcia, Carlos, Ferrer-Mayorga, Gemma, González-Rodríguez, Águeda, Valverde, Ángela M., Martín-Duce, Antonio, Velasco-Martín, Juan P., Regadera, Javier, Fernández, Margarita, Alemany, Susana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15351
container_issue 21
container_start_page 15342
container_title The Journal of biological chemistry
container_volume 288
creator Sanz-Garcia, Carlos
Ferrer-Mayorga, Gemma
González-Rodríguez, Águeda
Valverde, Ángela M.
Martín-Duce, Antonio
Velasco-Martín, Juan P.
Regadera, Javier
Fernández, Margarita
Alemany, Susana
description Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms. Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily. Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells. Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2. Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.
doi_str_mv 10.1074/jbc.M112.439547
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3663553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820460697</els_id><sourcerecordid>23572518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</originalsourceid><addsrcrecordid>eNp1kFtLwzAUx4Mobk6ffZN-gW5J07TNizCGl8FE8AK-hTQ9cRltWtJssG9vRnXog-flPPwvh_ND6JrgKcF5OtuUavpESDJNKWdpfoLGBBc0pox8nKIxxgmJecKKEbro-w0Ok3JyjkYJZXnCSDFGL68enKkhWlpdy6aR3rQ2MjaaK_CyMbbt1mBjY6utgipamR244N1s3T5a9tETVEb6IJT7aNH6me_q5BKdaVn3cPW9J-j9_u5t8Rivnh-Wi_kqVmnBfUw00ZhqlmqmUpmlpWaE6zwvgVZc6qIAgEQnWam4zFlWEkZ1nuVMZxgzyIBO0O3Q223LBioF1jtZi86ZRrq9aKURfxVr1uKz3QmaZZQxGgpmQ4Fybd870McsweKAVwS84oBXDHhD4ub3yaP_h2cw8MEA4fGdASd6ZcAGdMaB8qJqzb_lXwzIi3Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sanz-Garcia, Carlos ; Ferrer-Mayorga, Gemma ; González-Rodríguez, Águeda ; Valverde, Ángela M. ; Martín-Duce, Antonio ; Velasco-Martín, Juan P. ; Regadera, Javier ; Fernández, Margarita ; Alemany, Susana</creator><creatorcontrib>Sanz-Garcia, Carlos ; Ferrer-Mayorga, Gemma ; González-Rodríguez, Águeda ; Valverde, Ángela M. ; Martín-Duce, Antonio ; Velasco-Martín, Juan P. ; Regadera, Javier ; Fernández, Margarita ; Alemany, Susana</creatorcontrib><description>Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms. Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily. Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells. Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2. Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M112.439547</identifier><identifier>PMID: 23572518</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetaminophen - adverse effects ; Acetaminophen - pharmacology ; Alanine Transaminase - blood ; Alanine Transaminase - genetics ; Analgesics, Non-Narcotic - adverse effects ; Analgesics, Non-Narcotic - pharmacology ; Animals ; Aspartate Aminotransferases - blood ; Aspartate Aminotransferases - genetics ; Cell Line, Transformed ; Chemical and Drug Induced Liver Injury - enzymology ; Chemical and Drug Induced Liver Injury - genetics ; Chemical and Drug Induced Liver Injury - pathology ; Cytokine ; Drug Action ; ERK ; Hepatocyte ; Inflammation ; Interleukin-1alpha - genetics ; Interleukin-1alpha - metabolism ; Leukocyte ; Liver - enzymology ; Liver - pathology ; Liver Injury ; Macrophages ; Macrophages - enzymology ; Macrophages - pathology ; MAP Kinase Kinase 4 - genetics ; MAP Kinase Kinase 4 - metabolism ; MAP Kinase Kinase Kinases - genetics ; MAP Kinase Kinase Kinases - metabolism ; MAP Kinase Signaling System - drug effects ; MAP Kinase Signaling System - genetics ; Mice ; Mice, Knockout ; Mitogen-Activated Protein Kinase 3 - genetics ; Mitogen-Activated Protein Kinase 3 - metabolism ; Molecular Bases of Disease ; Necrosis (Necrotic Death) ; Neutrophil Infiltration - drug effects ; Neutrophil Infiltration - genetics ; Neutrophils - enzymology ; Neutrophils - pathology ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism</subject><ispartof>The Journal of biological chemistry, 2013-05, Vol.288 (21), p.15342-15351</ispartof><rights>2013 © 2013 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2013 by The American Society for Biochemistry and Molecular Biology, Inc. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</citedby><cites>FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663553/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663553/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23572518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sanz-Garcia, Carlos</creatorcontrib><creatorcontrib>Ferrer-Mayorga, Gemma</creatorcontrib><creatorcontrib>González-Rodríguez, Águeda</creatorcontrib><creatorcontrib>Valverde, Ángela M.</creatorcontrib><creatorcontrib>Martín-Duce, Antonio</creatorcontrib><creatorcontrib>Velasco-Martín, Juan P.</creatorcontrib><creatorcontrib>Regadera, Javier</creatorcontrib><creatorcontrib>Fernández, Margarita</creatorcontrib><creatorcontrib>Alemany, Susana</creatorcontrib><title>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms. Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily. Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells. Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2. Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.</description><subject>Acetaminophen - adverse effects</subject><subject>Acetaminophen - pharmacology</subject><subject>Alanine Transaminase - blood</subject><subject>Alanine Transaminase - genetics</subject><subject>Analgesics, Non-Narcotic - adverse effects</subject><subject>Analgesics, Non-Narcotic - pharmacology</subject><subject>Animals</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Aspartate Aminotransferases - genetics</subject><subject>Cell Line, Transformed</subject><subject>Chemical and Drug Induced Liver Injury - enzymology</subject><subject>Chemical and Drug Induced Liver Injury - genetics</subject><subject>Chemical and Drug Induced Liver Injury - pathology</subject><subject>Cytokine</subject><subject>Drug Action</subject><subject>ERK</subject><subject>Hepatocyte</subject><subject>Inflammation</subject><subject>Interleukin-1alpha - genetics</subject><subject>Interleukin-1alpha - metabolism</subject><subject>Leukocyte</subject><subject>Liver - enzymology</subject><subject>Liver - pathology</subject><subject>Liver Injury</subject><subject>Macrophages</subject><subject>Macrophages - enzymology</subject><subject>Macrophages - pathology</subject><subject>MAP Kinase Kinase 4 - genetics</subject><subject>MAP Kinase Kinase 4 - metabolism</subject><subject>MAP Kinase Kinase Kinases - genetics</subject><subject>MAP Kinase Kinase Kinases - metabolism</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>MAP Kinase Signaling System - genetics</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mitogen-Activated Protein Kinase 3 - genetics</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Molecular Bases of Disease</subject><subject>Necrosis (Necrotic Death)</subject><subject>Neutrophil Infiltration - drug effects</subject><subject>Neutrophil Infiltration - genetics</subject><subject>Neutrophils - enzymology</subject><subject>Neutrophils - pathology</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kFtLwzAUx4Mobk6ffZN-gW5J07TNizCGl8FE8AK-hTQ9cRltWtJssG9vRnXog-flPPwvh_ND6JrgKcF5OtuUavpESDJNKWdpfoLGBBc0pox8nKIxxgmJecKKEbro-w0Ok3JyjkYJZXnCSDFGL68enKkhWlpdy6aR3rQ2MjaaK_CyMbbt1mBjY6utgipamR244N1s3T5a9tETVEb6IJT7aNH6me_q5BKdaVn3cPW9J-j9_u5t8Rivnh-Wi_kqVmnBfUw00ZhqlmqmUpmlpWaE6zwvgVZc6qIAgEQnWam4zFlWEkZ1nuVMZxgzyIBO0O3Q223LBioF1jtZi86ZRrq9aKURfxVr1uKz3QmaZZQxGgpmQ4Fybd870McsweKAVwS84oBXDHhD4ub3yaP_h2cw8MEA4fGdASd6ZcAGdMaB8qJqzb_lXwzIi3Y</recordid><startdate>20130524</startdate><enddate>20130524</enddate><creator>Sanz-Garcia, Carlos</creator><creator>Ferrer-Mayorga, Gemma</creator><creator>González-Rodríguez, Águeda</creator><creator>Valverde, Ángela M.</creator><creator>Martín-Duce, Antonio</creator><creator>Velasco-Martín, Juan P.</creator><creator>Regadera, Javier</creator><creator>Fernández, Margarita</creator><creator>Alemany, Susana</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20130524</creationdate><title>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</title><author>Sanz-Garcia, Carlos ; Ferrer-Mayorga, Gemma ; González-Rodríguez, Águeda ; Valverde, Ángela M. ; Martín-Duce, Antonio ; Velasco-Martín, Juan P. ; Regadera, Javier ; Fernández, Margarita ; Alemany, Susana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetaminophen - adverse effects</topic><topic>Acetaminophen - pharmacology</topic><topic>Alanine Transaminase - blood</topic><topic>Alanine Transaminase - genetics</topic><topic>Analgesics, Non-Narcotic - adverse effects</topic><topic>Analgesics, Non-Narcotic - pharmacology</topic><topic>Animals</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Aspartate Aminotransferases - genetics</topic><topic>Cell Line, Transformed</topic><topic>Chemical and Drug Induced Liver Injury - enzymology</topic><topic>Chemical and Drug Induced Liver Injury - genetics</topic><topic>Chemical and Drug Induced Liver Injury - pathology</topic><topic>Cytokine</topic><topic>Drug Action</topic><topic>ERK</topic><topic>Hepatocyte</topic><topic>Inflammation</topic><topic>Interleukin-1alpha - genetics</topic><topic>Interleukin-1alpha - metabolism</topic><topic>Leukocyte</topic><topic>Liver - enzymology</topic><topic>Liver - pathology</topic><topic>Liver Injury</topic><topic>Macrophages</topic><topic>Macrophages - enzymology</topic><topic>Macrophages - pathology</topic><topic>MAP Kinase Kinase 4 - genetics</topic><topic>MAP Kinase Kinase 4 - metabolism</topic><topic>MAP Kinase Kinase Kinases - genetics</topic><topic>MAP Kinase Kinase Kinases - metabolism</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>MAP Kinase Signaling System - genetics</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mitogen-Activated Protein Kinase 3 - genetics</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Molecular Bases of Disease</topic><topic>Necrosis (Necrotic Death)</topic><topic>Neutrophil Infiltration - drug effects</topic><topic>Neutrophil Infiltration - genetics</topic><topic>Neutrophils - enzymology</topic><topic>Neutrophils - pathology</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sanz-Garcia, Carlos</creatorcontrib><creatorcontrib>Ferrer-Mayorga, Gemma</creatorcontrib><creatorcontrib>González-Rodríguez, Águeda</creatorcontrib><creatorcontrib>Valverde, Ángela M.</creatorcontrib><creatorcontrib>Martín-Duce, Antonio</creatorcontrib><creatorcontrib>Velasco-Martín, Juan P.</creatorcontrib><creatorcontrib>Regadera, Javier</creatorcontrib><creatorcontrib>Fernández, Margarita</creatorcontrib><creatorcontrib>Alemany, Susana</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sanz-Garcia, Carlos</au><au>Ferrer-Mayorga, Gemma</au><au>González-Rodríguez, Águeda</au><au>Valverde, Ángela M.</au><au>Martín-Duce, Antonio</au><au>Velasco-Martín, Juan P.</au><au>Regadera, Javier</au><au>Fernández, Margarita</au><au>Alemany, Susana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2013-05-24</date><risdate>2013</risdate><volume>288</volume><issue>21</issue><spage>15342</spage><epage>15351</epage><pages>15342-15351</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms. Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily. Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells. Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2. Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23572518</pmid><doi>10.1074/jbc.M112.439547</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2013-05, Vol.288 (21), p.15342-15351
issn 0021-9258
1083-351X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3663553
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Acetaminophen - adverse effects
Acetaminophen - pharmacology
Alanine Transaminase - blood
Alanine Transaminase - genetics
Analgesics, Non-Narcotic - adverse effects
Analgesics, Non-Narcotic - pharmacology
Animals
Aspartate Aminotransferases - blood
Aspartate Aminotransferases - genetics
Cell Line, Transformed
Chemical and Drug Induced Liver Injury - enzymology
Chemical and Drug Induced Liver Injury - genetics
Chemical and Drug Induced Liver Injury - pathology
Cytokine
Drug Action
ERK
Hepatocyte
Inflammation
Interleukin-1alpha - genetics
Interleukin-1alpha - metabolism
Leukocyte
Liver - enzymology
Liver - pathology
Liver Injury
Macrophages
Macrophages - enzymology
Macrophages - pathology
MAP Kinase Kinase 4 - genetics
MAP Kinase Kinase 4 - metabolism
MAP Kinase Kinase Kinases - genetics
MAP Kinase Kinase Kinases - metabolism
MAP Kinase Signaling System - drug effects
MAP Kinase Signaling System - genetics
Mice
Mice, Knockout
Mitogen-Activated Protein Kinase 3 - genetics
Mitogen-Activated Protein Kinase 3 - metabolism
Molecular Bases of Disease
Necrosis (Necrotic Death)
Neutrophil Infiltration - drug effects
Neutrophil Infiltration - genetics
Neutrophils - enzymology
Neutrophils - pathology
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
title Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A22%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sterile%20Inflammation%20in%20Acetaminophen-induced%20Liver%20Injury%20Is%20Mediated%20by%20Cot/tpl2&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Sanz-Garcia,%20Carlos&rft.date=2013-05-24&rft.volume=288&rft.issue=21&rft.spage=15342&rft.epage=15351&rft.pages=15342-15351&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M112.439547&rft_dat=%3Cpubmed_cross%3E23572518%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23572518&rft_els_id=S0021925820460697&rfr_iscdi=true